Cargando…

The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma

Aim: To investigate the relationship between PI3K/Akt/NF-κB cellular signal pathway and the expression of P-gp and LRP in multidrug resistance (MDR) cell of nasopharyngeal carcinoma. Method: The PI3K, p-Akt and NF-κB/p65 as the activity of PI3K/Akt/NF-κB were detected by Western blot. The expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jin, Zhu, Mingyi, Feng, Yun, Tang, Qianli, Xu, Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253406/
https://www.ncbi.nlm.nih.gov/pubmed/32400857
http://dx.doi.org/10.1042/BSR20190239
_version_ 1783539331145662464
author Liu, Jin
Zhu, Mingyi
Feng, Yun
Tang, Qianli
Xu, Meng
author_facet Liu, Jin
Zhu, Mingyi
Feng, Yun
Tang, Qianli
Xu, Meng
author_sort Liu, Jin
collection PubMed
description Aim: To investigate the relationship between PI3K/Akt/NF-κB cellular signal pathway and the expression of P-gp and LRP in multidrug resistance (MDR) cell of nasopharyngeal carcinoma. Method: The PI3K, p-Akt and NF-κB/p65 as the activity of PI3K/Akt/NF-κB were detected by Western blot. The expressions of LRP and P-gp were detected by Western blot and real-time PCR. Result: The RIs of CNE/DDP group to DDP, 5-Fu, VCR, ADR and PTX were 35.04, 18.14, 24.13, 12.00 and 10.18, respectively. The RIs of LY-294002 group were 11.77, 5.83, 3.07, 3.86 and 3.34, and PDTC group were 11.08, 6.55, 7.66, 2.18 and 4.05. The expressions of PI3K, p-Akt and NF-κBp65, LRP and P-gp were increased and mRNA of LRP and P-gp were up-regulated in CNE/DDP. The expression of p-Akt in LY-294002 group was down-regulated. The expression of NF-κB p65 in PDTC group was decreased. The mRNA of LRP and P-gp in LY-294002 group and PDTC group were decreased. Conclusion: MDR of nasopharyngeal carcinoma cell can be regulated by activating PI3K/Akt/NF-κB signal pathway and then increase the expression of P-gp and LRP. The MDR of nasopharyngeal carcinoma cell can be reversed by inhibiting PI3K/Akt/NF-κB signal pathway.
format Online
Article
Text
id pubmed-7253406
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72534062020-06-08 The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma Liu, Jin Zhu, Mingyi Feng, Yun Tang, Qianli Xu, Meng Biosci Rep Cancer Aim: To investigate the relationship between PI3K/Akt/NF-κB cellular signal pathway and the expression of P-gp and LRP in multidrug resistance (MDR) cell of nasopharyngeal carcinoma. Method: The PI3K, p-Akt and NF-κB/p65 as the activity of PI3K/Akt/NF-κB were detected by Western blot. The expressions of LRP and P-gp were detected by Western blot and real-time PCR. Result: The RIs of CNE/DDP group to DDP, 5-Fu, VCR, ADR and PTX were 35.04, 18.14, 24.13, 12.00 and 10.18, respectively. The RIs of LY-294002 group were 11.77, 5.83, 3.07, 3.86 and 3.34, and PDTC group were 11.08, 6.55, 7.66, 2.18 and 4.05. The expressions of PI3K, p-Akt and NF-κBp65, LRP and P-gp were increased and mRNA of LRP and P-gp were up-regulated in CNE/DDP. The expression of p-Akt in LY-294002 group was down-regulated. The expression of NF-κB p65 in PDTC group was decreased. The mRNA of LRP and P-gp in LY-294002 group and PDTC group were decreased. Conclusion: MDR of nasopharyngeal carcinoma cell can be regulated by activating PI3K/Akt/NF-κB signal pathway and then increase the expression of P-gp and LRP. The MDR of nasopharyngeal carcinoma cell can be reversed by inhibiting PI3K/Akt/NF-κB signal pathway. Portland Press Ltd. 2020-05-27 /pmc/articles/PMC7253406/ /pubmed/32400857 http://dx.doi.org/10.1042/BSR20190239 Text en © 2020 The Author(s). https://creativecommons.org/licenses/by/4.0/ This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
spellingShingle Cancer
Liu, Jin
Zhu, Mingyi
Feng, Yun
Tang, Qianli
Xu, Meng
The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma
title The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma
title_full The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma
title_fullStr The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma
title_full_unstemmed The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma
title_short The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma
title_sort multidrug resistance can be reversed for the decrease of p-gp and lrp by inhibiting pi3k/akt/nf-κb signal pathway in nasopharynx carcinoma
topic Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253406/
https://www.ncbi.nlm.nih.gov/pubmed/32400857
http://dx.doi.org/10.1042/BSR20190239
work_keys_str_mv AT liujin themultidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma
AT zhumingyi themultidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma
AT fengyun themultidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma
AT tangqianli themultidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma
AT xumeng themultidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma
AT liujin multidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma
AT zhumingyi multidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma
AT fengyun multidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma
AT tangqianli multidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma
AT xumeng multidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma